John Adams

Archer-Daniels-Midland ( NYSE:ADM – Free Report had its price target reduced by Morgan Stanley from $57.00 to $52.00 in a research report sent to investors on Tuesday morning, Benzinga reports.

RAPT Therapeutics ( NASDAQ:RAPT – Free Report had its target price cut by Wells Fargo & Company from $17.00 to $4.00 in a report published on Tuesday morning, Benzinga reports.

Other institutional investors have also recently made changes to their positions in the company.

A number of other large investors also recently bought and sold shares of the company. Blue Trust Inc. grew its holdings in Grocery Outlet by 76.6% during the third quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business.

Neuberger Berman Real Estate Securities Income Fund has decreased its dividend by an average of 8.0% annually over the last three years.

Sabra Health Care REIT has decreased its dividend by an average of 3.9% per year over the last three years.

The Financial Conduct Authority has instructed the Treasury to designate certain technology firms as "critical technology providers," or firms that

Literary contributors had different opinions on my email column last week about wildly popular Tennessee safety Will Brooks

SAGE ASIS ACT Dinner & Training Nearly Sold Out – There are only 20 tickets left for the SAGE ASIS ACT Annual Dinner, to be held at the Press Club in Canberra after SAGE next Thursday, November 21.